Ramya S. Gaddikeri
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ramya S. Gaddikeri has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Palmi Shah
Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, 1620 W Harrison St, Chicago, IL 60612
5 shared publications - Jennifer A. Febbo
From the Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, 1653 W Congress Pkwy, Jelke 181, Chicago, IL 60612
2 shared publications Kaitlin M. Robling
From the Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, 1653 W Congress Pkwy, Chicago, IL 60612
1 shared publicationMaham Jehangir
From the Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, 1653 W Congress Pkwy, Chicago, IL 60612
1 shared publication- Mohamed Z. Hussein
From the Department of Diagnostic Radiology and Nuclear Medicine, Rush University Medical Center, 1653 W Congress Pkwy, Chicago, IL 60612
1 shared publication
Latest Publications
- 1 June 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (3) , e251897
Case 347: Tracheobronchial Smooth Muscle Atrophy and Separation
History: A 69-year-old woman presented to her primary care physician with new-onset dysphonia and increasing shortness of breath, without chest pain. She described her voice as "going in and out" intermittently and reported an occasional cough. She also reported globus sensation without dysphagia. Her medical history included long-standing allergic rhinitis, arthritis, anemia, and gastroesophageal reflux disease. She had a documented history of asthma and had been using the inhaled steroid fluticasone (100 μg/d) since at least 2013, along with an albuterol inhaler as needed for the past 3 years. The patient was a current smoker with a 40-pack-year smoking history, though she had made intermittent attempts to quit. She had undergone yearly lung cancer screening with low-dose CT since 2019. On examination, there was no increased work of breathing, and her lungs were clear to auscultation, with no crackles or wheezing. Echocardiogram was normal. Pulmonary function tests showed severe obstruction: a forced expiratory volume in 1 second (FEV 1 ) of 0.6 L (lower limit of normal, 0.98 L), with a z-score of −2.5 to −4, and a ratio of FEV 1 to forced vital capacity of 0.33 (lower limit of normal, 0.67). There was negligible improvement in FEV 1 or forced vital capacity (less than 10%) after bronchodilator administration. Air trapping was present, with a residual volume greater than 120% predicted, and diffusion capacity for carbon monoxide was reduced to 51%. Oxygenation (oxygen saturation) on room air at rest was normal. An otolaryngologic consultation was requested for the patient’s new dysphonia, and flexible laryngoscopy was performed. Laryngoscopy revealed normal bilateral vocal cord movement but pachydermatous changes in the mucosa outlining the interarytenoid fold, which can be associated with nasopharyngeal reflux or chronic infection. As a part of the diagnostic workup for the increased shortness of breath, CT screening studies acquired in the patient in 2019, 2023, and 2024 were reviewed.
- 1 June 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 319 (3) , e251897
Case 347: Tracheobronchial Smooth Muscle Atrophy and Separation
History: A 69-year-old woman presented to her primary care physician with new-onset dysphonia and increasing shortness of breath, without chest pain. She described her voice as "going in and out" intermittently and reported an occasional cough. She also reported globus sensation without dysphagia. Her medical history included long-standing allergic rhinitis, arthritis, anemia, and gastroesophageal reflux disease. She had a documented history of asthma and had been using the inhaled steroid fluticasone (100 μg/d) since at least 2013, along with an albuterol inhaler as needed for the past 3 years. The patient was a current smoker with a 40-pack-year smoking history, though she had made intermittent attempts to quit. She had undergone yearly lung cancer screening with low-dose CT since 2019. On examination, there was no increased work of breathing, and her lungs were clear to auscultation, with no crackles or wheezing. Echocardiogram was normal. Pulmonary function tests showed severe obstruction: a forced expiratory volume in 1 second (FEV 1 ) of 0.6 L (lower limit of normal, 0.98 L), with a z-score of −2.5 to −4, and a ratio of FEV 1 to forced vital capacity of 0.33 (lower limit of normal, 0.67). There was negligible improvement in FEV 1 or forced vital capacity (less than 10%) after bronchodilator administration. Air trapping was present, with a residual volume greater than 120% predicted, and diffusion capacity for carbon monoxide was reduced to 51%. Oxygenation (oxygen saturation) on room air at rest was normal. An otolaryngologic consultation was requested for the patient’s new dysphonia, and flexible laryngoscopy was performed. Laryngoscopy revealed normal bilateral vocal cord movement but pachydermatous changes in the mucosa outlining the interarytenoid fold, which can be associated with nasopharyngeal reflux or chronic infection. As a part of the diagnostic workup for the increased shortness of breath, CT screening studies acquired in the patient in 2019, 2023, and 2024 were reviewed.
- 1 February 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (2) , e251896
Case 347
History A 69-year-old woman presented to her primary care physician with new-onset dysphonia and increasing shortness of breath, without chest pain. She described her voice as “going in and out” intermittently and reported an occasional cough. She also reported globus sensation without dysphagia. Her medical history included long-standing allergic rhinitis, arthritis, anemia, and gastroesophageal reflux disease. She had a documented history of asthma and had been using the inhaled steroid fluticasone (100 µg/d) since at least 2013, along with an albuterol inhaler as needed for the past 3 years. The patient was a current smoker with a 40-pack-year smoking history, though she had made intermittent attempts to quit. She had undergone yearly lung cancer screening with low-dose CT since 2019. On examination, there was no increased work of breathing, and her lungs were clear to auscultation, with no crackles or wheezing. Echocardiogram was normal. Pulmonary function tests showed severe obstruction: a forced expiratory volume in 1 second (FEV 1 ) of 0.6 L (lower limit of normal, 0.98 L), with a z-score of −2.5 to −4, and a ratio of FEV 1 to forced vital capacity of 0.33 (lower limit of normal, 0.67). There was negligible improvement in FEV 1 or forced vital capacity (less than 10%) after bronchodilator administration. Air trapping was present, with a residual volume greater than 120% predicted, and diffusion capacity for carbon monoxide was reduced to 51%. Oxygenation (oxygen saturation) on room air at rest was normal. An otolaryngologic consultation was requested for the patient's new dysphonia, and flexible laryngoscopy was performed. Laryngoscopy revealed normal bilateral vocal cord movement but pachydermatous changes in the mucosa outlining the interarytenoid fold, which can be associated with nasopharyngeal reflux or chronic infection. As a part of the diagnostic workup for the increased shortness of breath, CT screening studies acquired in the patient in 2019 ( Fig 1A ), 2023 ( Fig 1B ), and 2024 ( Fig 2 ) were reviewed.
- 1 February 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (2) , e251896
Case 347
History A 69-year-old woman presented to her primary care physician with new-onset dysphonia and increasing shortness of breath, without chest pain. She described her voice as “going in and out” intermittently and reported an occasional cough. She also reported globus sensation without dysphagia. Her medical history included long-standing allergic rhinitis, arthritis, anemia, and gastroesophageal reflux disease. She had a documented history of asthma and had been using the inhaled steroid fluticasone (100 µg/d) since at least 2013, along with an albuterol inhaler as needed for the past 3 years. The patient was a current smoker with a 40-pack-year smoking history, though she had made intermittent attempts to quit. She had undergone yearly lung cancer screening with low-dose CT since 2019. On examination, there was no increased work of breathing, and her lungs were clear to auscultation, with no crackles or wheezing. Echocardiogram was normal. Pulmonary function tests showed severe obstruction: a forced expiratory volume in 1 second (FEV 1 ) of 0.6 L (lower limit of normal, 0.98 L), with a z-score of −2.5 to −4, and a ratio of FEV 1 to forced vital capacity of 0.33 (lower limit of normal, 0.67). There was negligible improvement in FEV 1 or forced vital capacity (less than 10%) after bronchodilator administration. Air trapping was present, with a residual volume greater than 120% predicted, and diffusion capacity for carbon monoxide was reduced to 51%. Oxygenation (oxygen saturation) on room air at rest was normal. An otolaryngologic consultation was requested for the patient's new dysphonia, and flexible laryngoscopy was performed. Laryngoscopy revealed normal bilateral vocal cord movement but pachydermatous changes in the mucosa outlining the interarytenoid fold, which can be associated with nasopharyngeal reflux or chronic infection. As a part of the diagnostic workup for the increased shortness of breath, CT screening studies acquired in the patient in 2019 ( Fig 1A ), 2023 ( Fig 1B ), and 2024 ( Fig 2 ) were reviewed.
- 1 July 2024
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 44 (7) , e230150
Distinguishing Similar-appearing Chest Radiographs: Interactive Case-based Approach
- 1 July 2024
- Published by Radiological Society of North America (RSNA) in RadioGraphics
- Vol. 44 (7) , e230150
Distinguishing Similar-appearing Chest Radiographs: Interactive Case-based Approach
- 1 March 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 298 (3) , 713-716
Case 287: Intrathoracic Migration of a Breast Implant after Video-assisted Thoracoscopic Surgery for Right Upper Lobectomy
History A 60-year-old woman was diagnosed with a new right upper lobe stage I lung adenocarcinoma and underwent video-assisted thoracoscopic surgery (VATS) for right upper lobectomy. Her postoperat...
- 1 March 2021
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 298 (3) , 713-716
Case 287: Intrathoracic Migration of a Breast Implant after Video-assisted Thoracoscopic Surgery for Right Upper Lobectomy
History A 60-year-old woman was diagnosed with a new right upper lobe stage I lung adenocarcinoma and underwent video-assisted thoracoscopic surgery (VATS) for right upper lobectomy. Her postoperat...
- 1 November 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 297 (2) , 484-486
Case 287
History A 60-year-old woman was diagnosed with a new right upper lobe stage I lung adenocarcinoma and underwent video-assisted thoracoscopic surgery (VATS) for right upper lobectomy. Her postoperative course was complicated by a large pneumothorax after chest tube removal on postoperative day 3. This was managed with repeat right-sided chest tube placement on the same day. The second chest tube was removed on postoperative day 8 without complications. A 2-week postoperative clinic visit was unremarkable. Postoperative chest radiographs on postoperative days 1, 3, and 8 (Fig 1a- 1c) are provided. Subsequently, chest CT scanning was performed as part of routine 6-month postsurgical lung cancer surveillance follow-up (Figs 2, 3). The patient had no clinical complaints at routine follow-up. Physical examination revealed well-healed VATS scars in the chest wall. Laboratory results were within normal limits, including a normal white blood cell count of 6400/mL. Her surgical history included prior left upper lobectomy for remote left upper lobe stage IIIA adenocarcinoma and prior bilateral breast implantation for cosmesis. On the basis of chest CT findings, the patient was transferred from an outside institution.
- 1 November 2020
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 297 (2) , 484-486
Case 287
History A 60-year-old woman was diagnosed with a new right upper lobe stage I lung adenocarcinoma and underwent video-assisted thoracoscopic surgery (VATS) for right upper lobectomy. Her postoperative course was complicated by a large pneumothorax after chest tube removal on postoperative day 3. This was managed with repeat right-sided chest tube placement on the same day. The second chest tube was removed on postoperative day 8 without complications. A 2-week postoperative clinic visit was unremarkable. Postoperative chest radiographs on postoperative days 1, 3, and 8 (Fig 1a- 1c) are provided. Subsequently, chest CT scanning was performed as part of routine 6-month postsurgical lung cancer surveillance follow-up (Figs 2, 3). The patient had no clinical complaints at routine follow-up. Physical examination revealed well-healed VATS scars in the chest wall. Laboratory results were within normal limits, including a normal white blood cell count of 6400/mL. Her surgical history included prior left upper lobectomy for remote left upper lobe stage IIIA adenocarcinoma and prior bilateral breast implantation for cosmesis. On the basis of chest CT findings, the patient was transferred from an outside institution.